Cargando…
Pectolinarigenin inhibits non-small cell lung cancer progression by regulating the PTEN/PI3K/AKT signaling pathway
Lung cancer is the principal cause of cancer-associated mortality. Pectolinarigenin (Pec) reportedly has effective antitumor activity against certain cancer types. Phosphatase and tensin homolog (PTEN) is a well-known tumor suppressor and serves a vital role in cancer progression. However, the effec...
Autores principales: | Xu, Fei, Gao, Xuan, Pan, Huiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196644/ https://www.ncbi.nlm.nih.gov/pubmed/30542737 http://dx.doi.org/10.3892/or.2018.6759 |
Ejemplares similares
-
Pectolinarigenin Induced Cell Cycle Arrest, Autophagy, and Apoptosis in Gastric Cancer Cell via PI3K/AKT/mTOR Signaling Pathway
por: Lee, Ho Jeong, et al.
Publicado: (2018) -
Natural product pectolinarigenin inhibits proliferation, induces apoptosis, and causes G2/M phase arrest of HCC via PI3K/AKT/mTOR/ERK signaling pathway
por: Wu, Tianchun, et al.
Publicado: (2018) -
ACY1 regulating PTEN/PI3K/AKT signaling in the promotion of non-small cell lung cancer progression
por: Chen, Hong, et al.
Publicado: (2021) -
Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma
por: Fang, Yakun, et al.
Publicado: (2022) -
Upregulation of NFKBIZ affects bladder cancer progression via the PTEN/PI3K/Akt signaling pathway
por: Xu, Tao, et al.
Publicado: (2021)